Page last updated: 2024-08-23

etoposide and HIV

etoposide has been researched along with HIV in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19901 (8.33)18.7374
1990's3 (25.00)18.2507
2000's3 (25.00)29.6817
2010's4 (33.33)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Fazal, F; Gupta, N; Mittal, A; Ray, A1
Aboulafia, D; Ambinder, RF; Cesarman, E; Henry, D; Lee, J; Looney, D; Maldarelli, F; Mitsuyasu, R; Noy, A; Ramos, JC; Reid, EG; Sparano, J; Wachsman, W; Yahyaei, S1
Barta, SK; Boue, F; Dunleavy, K; Galicier, L; Garcia, O; Kaplan, LD; Lee, JY; Little, RF; Morgades, M; Mounier, N; Navarro, JT; Noy, A; Oriol, A; Ratner, L; Remick, SC; Ribera, JM; Sparano, JA; Spina, M; Tamari, R; Tirelli, U; Wang, D; Weiss, R; Wilson, WH; Wyen, C; Xue, X1
Aboulafia, D; Ambinder, RF; Cesarman, E; Chadburn, A; Dezube, BJ; Henry, DH; Kaplan, LD; Lee, JY; Leichman, L; Levine, AM; Mitsuyasu, R; Noy, A; Ramos, JC; Ratner, L; Remick, SC; Shah, MH; Sparano, JA; Von Roenn, J; Wachsman, W1
Carrasquillo, JA; Dunleavy, K; Grant, N; Jaffe, ES; Little, RF; Pittaluga, S; Steinberg, SM; Wayne, AS; Wilson, WH; Yarchoan, R1
Berry, C; Bushman, F; Chiang, CY; Mitchell, R1
Bushman, F; Groschel, B1
Becker, N; Leaf, A; Sparano, JA; Strack, M; Valentine, ES; Wiernik, PH1
Dutcher, JP; Henry, DH; Hu, X; Mason, B; Ratech, H; Sarta, C; Schwartz, EL; Soeiro, R; Sparano, JA; Wiernik, PH1
Cadeo, G; Carosi, G; Casari, S; Donisi, A; Re, A; Rossi, G; Stellini, R1
Fasan, M; Gabarre, J; Spina, M; Tirelli, U; Vaccher, E1
Church, JA; Lieberman, E; Malekzadeh, MH; Mitchell, WG; Opas, L; Siegel, SE1

Reviews

2 review(s) available for etoposide and HIV

ArticleYear
Haemophagocytic lymphohistiocytosis in human immunodeficiency virus: a systematic review of literature.
    Drug discoveries & therapeutics, 2020, Nov-04, Volume: 14, Issue:5

    Topics: Adult; Anti-Retroviral Agents; Etoposide; Female; HIV; HIV Infections; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Neoplasms; Opportunistic Infections; Retrospective Studies; Steroids; Topoisomerase II Inhibitors

2020
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients.
    Blood, 2013, Nov-07, Volume: 122, Issue:19

    Topics: Anti-HIV Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; HIV; HIV Infections; Humans; Infusions, Intravenous; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Prednisone; Rituximab; Survival Analysis; Treatment Outcome; Vincristine

2013

Trials

5 trial(s) available for etoposide and HIV

ArticleYear
Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas.
    Blood advances, 2018, 12-26, Volume: 2, Issue:24

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; APOBEC-3G Deaminase; Bortezomib; Carboplatin; Etoposide; Female; HIV; HIV Infections; Humans; Ifosfamide; Leukocytes, Mononuclear; Lymphoma; Male; Middle Aged; Oncolytic Virotherapy; Recurrence; Rituximab; Viral Load

2018
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.
    Blood, 2010, Apr-15, Volume: 115, Issue:15

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; HIV; Humans; Infusions, Intravenous; Lymphoma, B-Cell; Male; Middle Aged; Prednisone; Rituximab; Treatment Outcome; Vincristine

2010
The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma.
    Blood, 2010, Apr-15, Volume: 115, Issue:15

    Topics: Adolescent; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Child; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; HIV; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine; Viral Load; Young Adult

2010
Effects of recombinant granulocyte colony-stimulating factor (G-CSF) in patients treated with ProMACE-CytaBOM for HIV-related non-Hodgkin's lymphoma (NHL).
    Haematologica, 1998, Volume: 83, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; HIV; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Recombinant Proteins; Retrospective Studies; Treatment Outcome; Vincristine

1998
Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection.
    AIDS (London, England), 2000, Jul-07, Volume: 14, Issue:10

    Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Etoposide; Female; HIV; HIV Infections; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Male; Mechlorethamine; Middle Aged; Prednisone; Vinblastine; Vincristine

2000

Other Studies

5 other study(ies) available for etoposide and HIV

ArticleYear
Global analysis of cellular transcription following infection with an HIV-based vector.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2003, Volume: 8, Issue:4

    Topics: B-Lymphocytes; Etoposide; Gene Expression Profiling; Gene Transfer Techniques; Genetic Vectors; HIV; Humans; Nucleic Acid Synthesis Inhibitors; Oligonucleotide Array Sequence Analysis; Phylogeny

2003
Cell cycle arrest in G2/M promotes early steps of infection by human immunodeficiency virus.
    Journal of virology, 2005, Volume: 79, Issue:9

    Topics: Aphidicolin; Camptothecin; Cell Cycle; Cell Division; Cell Line; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; G2 Phase; HIV; HIV Infections; Humans; Nucleic Acid Synthesis Inhibitors; Paclitaxel; Time Factors; Transduction, Genetic; Virus Replication

2005
Infusional cyclophosphamide, doxorubicin, and etoposide in human immunodeficiency virus- and human T-cell leukemia virus type I-related non-Hodgkin's lymphoma: a highly active regimen.
    Blood, 1993, May-15, Volume: 81, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; HIV; HIV Infections; HIV Seropositivity; HTLV-I Infections; Humans; Infusions, Intravenous; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prognosis; Survival Analysis; Time Factors

1993
Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; CD4 Lymphocyte Count; Cyclophosphamide; Didanosine; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; HIV; HIV Core Protein p24; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pilot Projects; Recombinant Proteins; Survival Rate; Viremia

1996
Human immunodeficiency virus-associated Kaposi's sarcoma in a pediatric renal transplant recipient.
    Nephron, 1987, Volume: 47, Issue:1

    Topics: Blood Transfusion; Child; Etoposide; HIV; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Sarcoma, Kaposi

1987